IPO GMP, subscription race: Reliance Jio Platforms vs Paras Healthcare - Grey market premium, QIB, NII, Retail details
New Delhi, Oct. 25 -- Reliance Jio Platforms and Paras Healthcare IPOs witnessed contrasting levels of investor demand, with the former attracting bids worth several lakh crore rupees and the latter closing its subscription with a more modest response. While Jio Platforms' IPO was subscribed 22.19 times, driven by strong institutional participation, Paras Healthcare's public issue was subscribed 2.23 times on the final day of bidding.
The grey market premium (GMP) also points to a sharp difference in listing expectations. Jio Platforms' IPO GMP stood at Rs.250, implying a potential listing gain of around 22.34% over the upper end of its price band, while Paras Healthcare's GMP was Rs.12, indicating a potential gain of 1.73%. Grey market ...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.